The Journal of Rare Diseases and Orphan Drugs (JRDOD) is a peer-reviewed, double-blind, open-access medical journal that publishes original research, reviews, case reports, and letters covering a broad field of its specialty. We intend to publish articles that are stimulating to read, educate, and inform readers with the most up-to-date research in genetics, rare diseases, and new orphan drug development in different stages of clinical trials. Journal topics center on patients living with undiagnosed rare diseases, the importance of a diagnosis, and individual approaches to treatments. The journal is indexed in CiteFactor, Academic Resource Index, Scilit, and the ICI World of Journals, ROAD (https://portal.issn.org/resource/ISSN/2766-9696) - one of the largest international databases of scientific journals.
We are looking for papers from rare disease medical experts to contribute and share their knowledge.
- To fill a niche for practical information about physiological, pharmacological, psychological, and pathological forces that lead to the development of rare diseases.
- To afford an international platform for meaningful interdisciplinary collaboration to promote safe, effective, and affordable global patient care with rare disease conditions.
- To connect conventional and evidence-based complementary medicine to produce overall wellness.
- To address all aspects of the patients’ life related to the rare disease conditions, including, but not limited to psychological aspects, caregiver support, medical care availability, multidisciplinary team approach.
View the journal's Editorial Board